Orion Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Orion Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.34K	Hold	80	–	–	﹤0.01%	428
2026 Q1	$6.01K	Hold	80	–	–	﹤0.01%	393
2025 Q4	$6.33K	Hold	80	–	–	﹤0.01%	417
2025 Q3	$5.23K	Hold	80	–	–	﹤0.01%	434
2025 Q2	$3.16K	Hold	80	–	–	﹤0.01%	427
2025 Q1	$2.41K	Hold	80	–	–	﹤0.01%	434
2024 Q4	$2.8K	Buy	+80	New	+$2.99K	﹤0.01%	428
2024 Q3	–	Sell	-80	Closed	-$3.81K	–	284
2024 Q2	$3.81K	Hold	80	–	–	﹤0.01%	385
2024 Q1	$3.47K	Buy	80 +42	+111%	+$2K	﹤0.01%	442
2023 Q4	$1.92K	Hold	38	–	–	﹤0.01%	467
2023 Q3	$1.72K	Buy	+38	New	+$1.57K	﹤0.01%	461
2023 Q2	–	Sell	-38	Closed	-$1.36K	–	290
2023 Q1	$1.36K	Hold	38	–	–	﹤0.01%	439
2022 Q4	$1.44K	Hold	38	–	–	﹤0.01%	379
2022 Q3	$2K	Hold	38	–	–	﹤0.01%	383
2022 Q2	$1K	Hold	38	–	–	﹤0.01%	409
2022 Q1	$1K	Sell	38 -500	-93%	-$16.4K	﹤0.01%	400
2021 Q4	$16K	Buy	538 +500	+1,316%	+$15.7K	0.01%	276
2021 Q3	$1K	Hold	38	–	–	﹤0.01%	365
2021 Q2	$2K	Hold	38	–	–	﹤0.01%	292
2021 Q1	$2K	Hold	38	–	–	﹤0.01%	285
2020 Q4	$2K	Buy	+38	New	+$1.89K	﹤0.01%	283

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Orion Capital Management's IONS Position: Q2 2026 in Review

Orion Capital Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 80 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Orion Capital Management first reported a position in IONS in Q4 2020 and has held it in 21 quarters since. The position peaked at $16K in Q4 2021. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Orion Capital Management held 80 shares of Ionis Pharmaceuticals worth $6.34K as of Q2 2026.
Orion Capital Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #428 holding.
Orion Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
Orion Capital Management's Ionis Pharmaceuticals position peaked at $16K in Q4 2021.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.